| J9271 | Injection, pembrolizumab, 1 mg | 17,800 | $40 | $765.4K |
| J0897 | Injection, denosumab, 1 mg | 7,200 | $20 | $129.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 550 | $110 | $61.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $140 | $59.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 350 | $160 | $57.7K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 410 | $130 | $54.4K |
| Q5120 | Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg | 460 | $80 | $36.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 90 | $200 | $18K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 150 | $70 | $10.1K |
| J0185 | Injection, aprepitant, 1 mg | 8,710 | $1 | $8.7K |